Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation

Atherosclerosis

Volumn 194, Issue 1, 2007, Pages 272-278

  van Tits, L J H ^a   Jacobs, E M G ^a   Swinkels, D W ^a   Lemmers, H L M ^a   van der Vleuten, G M ^a   de Graaf, J ^a   Stalenhoef, A F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Inflammation; Intercellular adhesion molecule 1; Iron status; Low density lipoprotein oxidation; Non transferrin bound iron

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; IRON; LOW DENSITY LIPOPROTEIN; NONTRANSFERRIN BOUND IRON; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; FEMALE; HEMOCHROMATOSIS; HUMAN; IN VIVO STUDY; INFLAMMATION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LEUKOCYTE COUNT; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; STATISTICAL ANALYSIS;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; FEMALE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; IRON; LIPOPROTEINS, LDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OXIDATION-REDUCTION; RISK FACTORS; SOLUBILITY; TRANSFERRIN;

EID: 34648858604     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.012     Document Type: Article

References (38)

1. Danesh J., and Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 99 (1999) 852-854
2. de Valk B., and Marx J.J. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 159 (1999) 1542-1548
3. Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28 (2000) 1815-1826
4. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23 Suppl 1 (1993) 118-126
5. Hershko C., and Peto T.E. Non-transferrin plasma iron. Br J Haematol 66 (1987) 149-151
6. Gosriwatana I., Loreal O., Lu S., et al. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 273 (1999) 212-220
7. de Valk B., Addicks M.A., Gosriwatana I., et al. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30 (2000) 248-251
8. McCord J.M. Effects of positive iron status at a cellular level. Nutr Rev 54 (1996) 85-88
9. Breuer W., and Cabantchik Z.I. A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem 299 (2001) 194-202
10. Holvoet P., Mertens A., Verhamme P., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21 (2001) 844-848
11. Toshima S., Hasegawa A., Kurabayashi M., et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20 (2000) 2243-2247
12. Jacobs E.M., Hendriks J.C., van Tits B.L., et al. Results of an international round robin for the quantification of serum non-transferrin-bound iron: need for defining standardization and a clinically relevant isoform. Anal Biochem 341 (2005) 241-250
13. Derstine J.L., Murray-Kolb L.E., Yu-Poth S., et al. Iron status in association with cardiovascular disease risk in 3 controlled feeding studies. Am J Clin Nutr 77 (2003) 56-62
14. Brouwers A., Langlois M., Delanghe J., et al. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 176 (2004) 189-195
15. Iribarren C., Sempos C.T., Eckfeldt J.H., and Folsom A.R. Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis Risk in Communities. Atherosclerosis 139 (1998) 189-195
16. Tuomainen T.P., Diczfalusy U., Kaikkonen J., et al. Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. Free Radic Biol Med 35 (2003) 922-928
17. Van Hoydonck P.G., Schouten E.G., Hoppenbrouwers K.P., and Temme E.H. Is blood donation induced low iron status associated with favourable levels of OxLDL, s-ICAM-1, sVCAM-1 and vWF-antigen in healthy men. Atherosclerosis 172 (2004) 321-327
18. Lee D.H., and Jacobs Jr. D.R. Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin. Med Hypotheses 62 (2004) 442-445
19. Demacker P.N., Hessels M., Toenhake-Dijkstra H., and Baadenhuijsen H. Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio. Clin Chem 43 (1997) 663-668
20. Lopes-Virella M.F., Virella G., Evans G., et al. Immunonephelometric assay of human apolipoprotein AI. Clin Chem 26 (1980) 1205-1208
21. Leeuwenberg J.F., Smeets E.F., Neefjes J.J., et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 77 (1992) 543-549
22. Van Tits L., de Graaf J., Hak-Lemmers H., et al. Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Invest 83 (2003) 13-21
23. Holvoet P., Macy E., Landeloos M., et al. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin Chem 52 (2006) 760-764
24. van Tits L.J., De Waart F., Hak-Lemmers H.L., et al. Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Radic Biol Med 30 (2001) 1122-1129
25. de Kok J.B., Wiegerinck E.T., Giesendorf B.A., and Swinkels D.W. Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Hum Mutat 19 (2002) 554-559
26. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
27. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 (1998) 1236-1238
28. Perneger T.V. Adjusting for multiple testing in studies is less important than other concerns. BMJ 318 (1999) 1288
29. Kartikasari A.E., Georgiou N.A., Visseren F.L., et al. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J 20 (2006) 353-355
30. Kartikasari A.E., Georgiou N.A., Visseren F.L., et al. Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler Thromb Vasc Biol 24 (2004) 2257-2262
31. Adams D.H., and Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343 (1994) 831-836
32. Nageh M.F., Sandberg E.T., Marotti K.R., et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 17 (1997) 1517-1520
33. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191-203
34. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (1998) 88-92
35. Kondo K., Kitagawa K., Nagai Y., et al. Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis 179 (2005) 155-160
36. Williams M.J., Poulton R., and Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 165 (2002) 179-184
37. Van Tits L.J.H., Jacobs E.M.G., Swinkels D.W., et al. Serum non-transferrin-bound iron and low-density lipoprotein oxidation in heterozygous hemochromatosis. Biochem Biophys Res Commun 345 (2006) 371-376
38. Salahudeen A.K., Oliver B., Bower J.D., and Roberts L.J. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int 60 (2001) 1525-1531